LD-2 disclosure · 2nd Quarter - Report
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Client
- Description
- Informal coalition of health and consumer organizations and sunscreen industry companies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Implementation of the over the counter drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on over-the-counter sunscreen ingredients; FDA jurisdiction over determinations regarding the safety and efficacy and OTC status of sunscreens; sunscreen provisions in the FY 2024 House and Senate appropriations for the Food and Drug Administration (H.R. 4368 and S. 2131); issues related to sunscreen use and coral reefs; implementation of the National Academies of Sciences report on sunscreen; skin cancer prevention for outdoor workers.
LobbyistsJOEL ROBERSON · MICHAEL WERNER · ETHAN JORGENSEN-EARP · ASHLEY LAWRENCE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Environmental Protection Agency (EPA)